Intracellular Ca2+ signaling machinery in platelets

The intracellular Ca2+ signaling machinery in platelets is a sophisticated network of proteins and organelles that orchestrates the rapid and precise changes in cytosolic calcium levels required for platelet function. This machinery includes the dense tubular system (the primary calcium store), various plasma membrane channels (such as Orai1, TRPC6, and P2X1), and intracellular sensors like STIM1 that detect store depletion (nih.gov, 2021) [1.1.3]. Upon activation by agonists like thrombin or collagen, calcium is released via IP3 receptors and subsequently replenished through store-operated calcium entry (SOCE), a process central to sustained platelet activation and the formation of procoagulant platelets (tandfonline.com, 2021) [1.1.1]. Dysregulation of this machinery is a key driver of pathological thrombus formation, contributing to arterial diseases such as myocardial infarction and ischemic stroke (nih.gov, 2020) [1.2.3]. Because different components of the calcium signaling network contribute to distinct aspects of platelet function (e.g., aggregation vs. procoagulant activity), targeting specific elements like the STIM1-Orai1 axis offers the potential to decouple antithrombotic efficacy from bleeding risks (frontiersin.org, 2019) [1.3.5]. Current research focuses on small-molecule inhibitors of SOCE and other calcium-handling proteins as novel antiplatelet agents that may overcome the limitations of existing therapies (nih.gov, 2022) [1.1.5].

Other names

Platelet calcium signaling pathwayPlatelet Ca2+ homeostasis machineryStore-operated calcium entry (SOCE) machinery in plateletsPlatelet calcium signaling system

Inhibition of store-operated calcium entry (SOCE) via Orai1/STIM1, blockade of receptor-operated channels (P2X1), and modulation of intracellular stores (SERCA/IP3R) to prevent platelet activation and thrombus formation.